A Novel In Situ Gel Formulation of Ranitidine for Oral Sustained Delivery.
Biomolecules & Therapeutics.2014;22(2):161-165.
Animal Experimentation ; Gels ; Gingiva ; Ranitidine* ; Stomach ; Viscosity
Biomolecules & Therapeutics
2008 to Present ISSN: 1976-9148
Sort by
Format:
Per page:
A Novel In Situ Gel Formulation of Ranitidine for Oral Sustained Delivery.
Biomolecules & Therapeutics.2014;22(2):161-165.
Neurotoxicity of Synthetic Cannabinoids JWH-081 and JWH-210.
Biomolecules & Therapeutics.2015;23(6):597-603. doi:10.4062/biomolther.2015.057
Assessment of the Abuse Liability of Synthetic Cannabinoid Agonists JWH-030, JWH-175, and JWH-176.
Biomolecules & Therapeutics.2015;23(6):590-596. doi:10.4062/biomolther.2015.120
Biomolecules & Therapeutics.2015;23(6):582-589. doi:10.4062/biomolther.2015.128
Biomolecules & Therapeutics.2015;23(6):571-581. doi:10.4062/biomolther.2015.027
Biomolecules & Therapeutics.2014;22(3):200-206.
Britanin Suppresses IgE/Ag-Induced Mast Cell Activation by Inhibiting the Syk Pathway.
Biomolecules & Therapeutics.2014;22(3):193-199.
Biomolecules & Therapeutics.2014;22(3):184-192.
Biomolecules & Therapeutics.2014;22(3):176-183.
Harnessing of Programmed Necrosis for Fighting against Cancers.
Biomolecules & Therapeutics.2014;22(3):167-175.
Country
Republic of Korea
Publisher
Korean Society of Applied Pharmacology
ElectronicLinks
http://koreamed.org/JournalVolume.php?id=213Editor-in-chief
Young Ae Joe
editor@biomolther.org
Abbreviation
Biomol Ther
Vernacular Journal Title
ISSN
1976-9148
EISSN
2005-4483
Year Approved
2014
Current Indexing Status
Currently Indexed
Start Year
2008
Description